Newtyn Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-236,800
| Closed | -$497K | – | 74 |
|
|
2023
Q1 | $497K | Buy |
236,800
+6,800
| +3% | +$14.3K | 0.1% | 70 |
|
|
2022
Q4 | $375K | Buy |
230,000
+30,000
| +15% | +$48.9K | 0.08% | 65 |
|
|
2022
Q3 | $610K | Sell |
200,000
-48,611
| -20% | -$148K | 0.13% | 63 |
|
|
2022
Q2 | $782K | Buy |
+248,611
| New | +$782K | 0.15% | 65 |
|